AI assistant
REPLIGEN CORP — Director's Dealing 2018
Nov 28, 2018
30826_dirs_2018-11-28_50df9725-ee42-4b1f-bd52-75ebe4016c12.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: REPLIGEN CORP (RGEN)
CIK: 0000730272
Period of Report: 2018-11-26
Reporting Person: Snodgres Jon (CFO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-11-26 | Common Stock | M | 11445 | $26.20 | Acquired | 32344 | Direct |
| 2018-11-26 | Common Stock | M | 4000 | $24.50 | Acquired | 36344 | Direct |
| 2018-11-26 | Common Stock | M | 6055 | $32.40 | Acquired | 42399 | Direct |
| 2018-11-26 | Common Stock | M | 10253 | $26.05 | Acquired | 52652 | Direct |
| 2018-11-26 | Common Stock | S | 31753 | $63.4874 | Disposed | 20899 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-11-26 | Stock Option (Right to Buy) | $26.20 | M | 11445 | Disposed | 2025-02-26 | Common Stock (11445) | Direct |
| 2018-11-26 | Stock Option (Right to Buy) | $24.50 | M | 4000 | Disposed | 2024-07-14 | Common Stock (4000) | Direct |
| 2018-11-26 | Stock Option (Right to Buy) | $32.40 | M | 6055 | Disposed | 2027-02-23 | Common Stock (6055) | Direct |
| 2018-11-26 | Stock Option (Right to Buy) | $26.05 | M | 10253 | Disposed | 2026-02-26 | Common Stock (10253) | Direct |
Footnotes
F1: Sale of common stock was effective pursuant to a 10(b)5-1 trading plan adopted on September 19, 2018.
F2: $63.4874 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $63.18 to $64.71, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F3: This option is currently exercisable.
F4: 2,000 shares vest and become exercisable on each of the following dates: 7/14/2015, 7/14/2016, 7/14/2017, 7/14/2018 and 7/14/2019.
F5: 6,055 shares vest and become exercisable on each of the following dates: 2/23/2018, 2/23/2019 and 2/23/2020.
F6: Shares vest and become exercisable as follows: 5,126 shares on 2/26/2017, 5,127 shares on 2/26/2018 and 5,127 shares on 2/26/2019.